683 Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,265
| Closed | -$338K | – | 324 |
|
|
2022
Q1 | $338K | Sell |
18,265
-3,363
| -16% | -$62.2K | 0.02% | 209 |
|
|
2021
Q4 | $428K | Buy |
+21,628
| New | +$428K | 0.02% | 203 |
|
|
2020
Q1 | – | Sell |
-19,333
| Closed | -$139K | – | 173 |
|
|
2019
Q4 | $139K | Sell |
19,333
-98,403
| -84% | -$707K | 0.02% | 130 |
|
|
2019
Q3 | $1.29M | Hold |
117,736
| – | – | 0.14% | 60 |
|
|
2019
Q2 | $3.62M | Hold |
117,736
| – | – | 0.33% | 48 |
|
|
2019
Q1 | $4.93M | Buy |
117,736
+4,600
| +4% | +$193K | 0.45% | 36 |
|
|
2018
Q4 | $5.14M | Buy |
+113,136
| New | +$5.14M | 0.31% | 33 |
|
|
2018
Q3 | – | Sell |
-33,333
| Closed | -$3.21M | – | 167 |
|
|
2018
Q2 | $3.21M | Hold |
33,333
| – | – | 0.22% | 52 |
|
|
2018
Q1 | $3.51M | Buy |
+33,333
| New | +$3.51M | 0.31% | 50 |
|